Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY

Enveric Biosciences reported a Q4 loss of $(0.50) per share, significantly improving from a loss of $(57.96) per share in the same quarter last year, representing a 99.14% increase in performance. The company's stock is traded under the ticker ENVB on NASDAQ.